Prognostic factors for ovarian metastases from primary gastric cancer

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 825-832

  Wang, J ^a   Shi, Y K ^a   Wu, L Y ^a   Wang, J W ^a   Yang, S ^a   Yang, J L ^a   Zhang, H Z ^a   Liu, S M ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Chemotherapy; Combined modality therapy; Ovarian metastases; Primary gastric cancer; Prognostic factors

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY METASTASIS; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SIDE EFFECT; STOMACH CANCER; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TAXOIDS;

EID: 47649086618     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01078.x     Document Type: Article

References (19)

1. Moore RG, Chung M, Granai CO et al. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004 93 : 87 91.
2. Skirnisdottir I, Garmo H, Holmberg L. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007 105 : 166 71.
3. Gold JS, Jaques DP, Bentrem DJ et al. Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Ann Surg Oncol 2007 14 : 365 72.
4. Yada-Hashimoto N, Yamamoto T, Kamiura S et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003 89 : 314 7.
5. Cheong JH, Hyung WJ, Chen J et al. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 2004 94 : 477 82.
6. Kim NK, Kim HK, Park BJ et al. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer 1999 85 : 1490 9.
7. Duarte I, Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol 1981 12 : 237 42.
8. Stemmermann G, Brown C. A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 1974 33 : 1190 5.
9. Kim HK, Heo DS, Bang YJ et al. Prognostic factors of Krukenberg's tumor. Gynecol Oncol 2001 82 : 105 9.
10. Cheong JH, Hyung WJ, Chen J et al. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol 2004 87 : 39 45.
11. Mrad K, Morice P, Fabre A et al. Krukenberg tumor: a clinico-pathological study of 15 cases. Ann Pathol 2000 20 : 202 6.
12. Taylor AE, Nicolson VM, Cunningham D. Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment. Br J Cancer 1995 71 : 92 6.
13. Cunningham MD, Rao S, Starling N et al. Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: the REAL 2 trial. Proc Am Soc Clin Oncol 2006 24 : 182 (abstr LBA4017).
14. Kang Y, Kang WK, Shin DB et al. Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): efficacy and safety results. Proc Am Soc Clin Oncol 2006 24 : 183 (abstr LBA4018).
15. Moiseyenko VM, Ajani JA, Tjulandin SA et al. Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC). Proc Am Soc Clin Oncol 2005 23 : 308 (abstr 4002).
16. Wagner AD, Grothe W, Haerting J et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006 24 : 2903 9.
17. Akhan S, Kilic G, Salihoglu Y et al. Nongenital metastatic cancers of the ovary: a clinical analysis. Eur J Gynaecol Oncol 2001 22 : 379 83.
18. Fujiwara K, Armstrong D, Morgan M et al. Principles and practice of intraperitoneal chemotherapy for ovarian cancer. Int J Gynecol Cancer 2007 17 : 1 20.
19. Fujiwara K, Ohishi Y, Koike H et al. Clinical implications of metastases to the ovary. Gynecol Oncol 1995 59 : 124 8.